Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus

Vaccine

Volumn 29, Issue 15, 2011, Pages 2712-2719

  Gauger, Phillip C ^a,b   Vincent, Amy L ^a   Loving, Crystal L ^a   Lager, Kelly M ^a   Janke, Bruce H ^b   Kehrli, Marcus E ^a   Roth, James A ^b  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Enhanced pneumonia; Pandemic H1N1; Swine influenza virus

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; CYTOKINE RELEASE; GENETIC DRIFT; GENETIC REASSORTMENT; HEMAGGLUTINATION INHIBITION; HISTOPATHOLOGY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H1N2; LUNG LAVAGE; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SWINE INFLUENZA; VIRUS NEUTRALIZATION; VIRUS PNEUMONIA; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H1N2 SUBTYPE; INFLUENZA VACCINES; LUNG; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; SEVERITY OF ILLNESS INDEX; SWINE; SWINE DISEASES; VIRUS SHEDDING;

EID: 79952244491     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.082     Document Type: Article

References (42)

1. Choi Y.K., Goyal S.M., Joo H.S. Prevalence of swine influenza virus subtypes on swine farms in the United States. Arch Virol 2002, 147(6):1209-1220.
2. Vincent A.L., Lager K.M., Ma W., Lekcharoensuk P., Gramer M.R., Loiacono C., et al. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vet Microbiol 2006, 118(3-4):212-222.
3. Vincent A.L., Ma W., Lager K.M., Janke B.H., Richt J.A. Swine influenza viruses a North American perspective. Adv Virus Res 2008, 72:127-154.
4. Webby R.J., Rossow K., Erickson G., Sims Y., Webster R. Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Virus Res 2004, 103(1-2):67-73.
5. Choi Y.K., Goyal S.M., Farnham M.W., Joo H.S. Phylogenetic analysis of H1N2 isolates of influenza A virus from pigs in the United States. Virus Res 2002, 87(2):173-179.
6. Karasin A.I., Carman S., Olsen C.W. Identification of human H1N2 and human-swine reassortant H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada (2003 to 2005). J Clin Microbiol 2006, 44(3):1123-1126.
7. Ma W., Gramer M., Rossow K., Yoon K.J. Isolation and genetic characterization of new reassortant H3N1 swine influenza virus from pigs in the midwestern United States. J Virol 2006, 80(10):5092-5096.
8. Olsen C.W., Karasin A.I., Carman S., Li Y., Bastien N., Ojkic D., et al. Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis 2006, 12(7):1132-1135.
9. Richt J.A., Lager K.M., Janke B.H., Woods R.D., Webster R.G., Webby R.J. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J Clin Microbiol 2003, 41(7):3198-3205.
10. Vincent A.L., Ma W., Lager K.M., Gramer M.R., Richt J.A., Janke B.H. Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Virus Genes 2009, 39:176-185.
11. Webby R.J., Swenson S.L., Krauss S.L., Gerrish P.J., Goyal S.M., Webster R.G. Evolution of swine H3N2 influenza viruses in the United States. J Virol 2000, 74(18):8243-8251.
12. Olsen C.W., Carey S., Hinshaw L., Karasin A.I. Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States. Arch Virol 2000, 145(7):1399-1419.
13. Ma W., Vincent A.L., Gramer M.R., Brockwell C.B., Lager K.M., Janke B.H., et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci U S A 2007, 104(52):20949-20954.
14. Vincent A.L., Swenson S.L., Lager K.M., Gauger P.C., Loiacono C., Zhang Y. Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. Vet Microbiol 2009, 137(1-2):51-59.
15. Bikour M.H., Cornaglia E., Elazhary Y. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs. Can J Vet Res 1996, 60(4):312-314.
16. Kitikoon P., Nilubol D., Erickson B.J., Janke B.H., Hoover T.C., Sornsen S.A., et al. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet Immunol Immunopathol 2006, 112(3-4):117-128.
17. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., et al. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol 1998, 72(2):1491-1496.
18. Van Reeth K., Brown I., Essen S., Pensaert M. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs. Virus Res 2004, 103(1-2):115-124.
19. Vincent A.L., Lager K.M., Janke B.H., Gramer M.R., Richt J.A. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vet Microbiol 2008, 126(4):310-323.
20. Van Reeth K., Gregory V., Hay A., Pensaert M. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine 2003, 21(13-14):1375-1381.
21. Kitikoon P., Vincent A.L., Janke B.H., Erickson B., Strait E.L., Yu S., et al. Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates. Vaccine 2009, 28(2):523-531.
22. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995, 32(6):648-660.
23. Opriessnig T., Yu S., Gallup J.M., Evans R.B., Fenaux M., Pallares F., et al. Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet Pathol 2003, 40(5):521-529.
24. Strait E.L., Madsen M.L., Minion F.C., Christopher-Hennings J., Dammen M., Jones K.R., et al. Real-time PCR assays to address genetic diversity among strains of Mycoplasma hyopneumoniae. J Clin Microbiol 2008, 46(8):2491-2498.
25. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am J Infect Control 1938, 27:493-497.
26. WHO WHO Manual on Animal Influenza Diagnosis and Surveillance 2002, Available from: http://www.wpro.who.int/NR/rdonlyres/EFD2B9A7-2265-4AD0-BC98-97937B4FA83C/0/manualonanimalaidiagnosisandsurveillance.pdf [accessed 14.06.10]. 2nd ed.
27. Larsen D.L., Karasin A., Zuckermann F., Olsen C.W. Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Vet Microbiol 2000, 74(1-2):117-131.
28. Brockmeier S.L., Lager K.M., Grubman M.J., Brough D.E., Ettyreddy D., Sacco R.E., et al. Adenovirus-mediated expression of interferon-alpha delays viral replication and reduces disease signs in swine challenged with porcine reproductive and respiratory syndrome virus. Viral Immunol 2009, 22(3):173-180.
29. Vincent A.L., Lager K.M., Faaberg K.S., Harland M., Zanella E.L., Ciacci-Zanella J.R., et al. Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respir Viruses 2010, 4(2):53-60.
30. Haesebrouck F., Biront P., Pensaert M.B., Leunen J. Epizootics of respiratory tract disease in swine in Belgium due to H3N2 influenza virus and experimental reproduction of disease. Am J Vet Res 1985, 46(9):1926-1928.
31. Baggiolini M., Loetscher P., Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995, 17(2):103-108.
32. Kitikoon P., Strait E.L., Thacker E.L. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure. Vet Microbiol 2008, 126(1-3):51-62.
33. Vincent A.L., Ma W., Lager K.M., Janke B.H., Webby R.J., Garcia-Sastre A., et al. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 2007, 25(47):7999-8009.
34. Heinen P.P., de Boer-Luijtze E.A., Bianchi A.T. Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection. J Gen Virol 2001, 82(Pt 11):2697-2707.
35. Yu H., Zhou Y.J., Li G.X., Zhang G.H., Liu H.L., Yan L.P., et al. Further evidence for infection of pigs with human-like H1N1 influenza viruses in China. Virus Res 2009, 140(1-2):85-90.
36. Monsalvo A.C., Batalle J.P., Lopez M.F., Krause J.C., Klemenc J., Hernandez J.Z., et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 2010, [Epub ahead of print].
37. Vella S., Rocchi G., Resta S., Marcelli M., De F.A. Antibody reactive in antibody-dependent cell-mediated cytotoxicity following influenza virus vaccination. J Med Virol 1980, 6(3):203-211.
38. Jegerlehner A., Schmitz N., Storni T., Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 2004, 172(9):5598-5605.
39. Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 2002, 8(4):373-378.
40. Heinen P.P., Rijsewijk F.A., de Boer-Luijtze E.A., Bianchi A.T. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol 2002, 83(Pt 8):1851-1859.
41. Skowronski D.M., De Serres G., Crowcroft N.S., Janjua N.Z., Boulianne N., Hottes T.S., et al. Association between the 2008-09 seasonal influenza vaccine and pandemic h1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010, 7(4):1-15.
42. Vincent A.L., Ciacci-Zanella J.R., Lorusso A., Gauger P.C., Zanella E.L., Kehrli M.E., et al. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 2010, 28(15):2782-2787.